Effect of open-lung vs conventional perioperative ventilation strategies on postoperative pulmonary complications after on-pump cardiac surgery: the PROVECS randomized clinical trial

Abstract

Purpose:

To evaluate whether a perioperative open-lung ventilation strategy prevents postoperative pulmonary complications after elective on-pump cardiac surgery.

Methods:

In a pragmatic, randomized, multicenter, controlled trial, we assigned patients planned for on-pump cardiac surgery to either a conventional ventilation strategy with no ventilation during cardiopulmonary bypass (CPB) and lower perioperative positive end-expiratory pressure (PEEP) levels (2 cm H₂O) or an open-lung ventilation strategy that included maintaining ventilation during CPB along with perioperative recruitment maneuvers and higher PEEP levels (8 cm H ₂O). All study patients were ventilated with low-tidal volumes before and after CPB (6 to 8 ml/kg of predicted body weight). The primary end point was a composite of pulmonary complications occurring within the first 7 postoperative days.

Results:

Among 493 randomized patients, 488 completed the study (mean age, 65.7 years; 360 (73.7%) men; 230 (47.1%) underwent isolated valve surgery). Postoperative pulmonary complications occurred in 133 of 243 patients (54.7%) assigned to open-lung ventilation and in 145 of 245 patients (59.2%) assigned to conventional ventilation (p = 0.32). Open-lung ventilation did not significantly reduce the use of high-flow nasal oxygenotherapy (8.6% vs 9.4%; p = 0.77), non-invasive ventilation (13.2% vs 15.5%; p = 0.46) or new invasive mechanical ventilation (0.8% vs 2.4%, p = 0.28). Mean alive ICU-free days at postoperative day 7 was 4.4 ± 1.3 days in the open-lung group vs 4.3 ± 1.3 days in the conventional group (mean difference, 0.1 ± 0.1 day, p = 0.51). Extra-pulmonary complications and adverse events did not significantly differ between groups.

Conclusions:

A perioperative open-lung ventilation including ventilation during CPB does not reduce the incidence of postoperative pulmonary complications as compared with usual care. This finding does not support the use of such a strategy in patients undergoing on-pump cardiac surgery.

Introduction

Every year an estimated 1.25 million patients undergo cardiac surgery with cardiopulmonary bypass (CPB) worldwide. Despite fast-track protocols, postoperative pulmonary complications, ranging from mild hypoxemia [1] to acute respiratory distress syndrome [2], are common after on-pump cardiac surgery [3]. Such postoperative complications have been shown to extend intensive care unit (ICU) stays [4], increase in-hospital mortality [5], and lead to adverse financial outcomes in health care [6].

Preventing postoperative pulmonary complications with the use of low-tidal-volume ventilation (6 to 8 ml per kilogram of predicted body weight [PBW]) is now an established consensus (protective ventilation) [7]. However, low tidal volumes promote alveolar collapse in poorly ventilated, dependent regions of the lung [8]. As a result, atelectrauma, secondary to the repetitive collapse and reopening of alveolar units, contributes to ventilator-induced lung injury [9]. The open-lung ventilation strategy corresponds to the use of recruitment maneuvers (‘open the lung’) associated with high levels of positive end-expiratory pressure (PEEP) in order to prevent alveolar collapse (‘keep it open’) [10, 11]. This approach has been shown to improve pulmonary mechanics [12]. However, its clinical benefit is still uncertain in surgical patients [13, 14].

In cardiac surgery, recruitment maneuvers and high levels of PEEP have traditionally been avoided [15]. In addition, mechanical ventilation is frequently interrupted during CPB, with or without disconnection of the breathing circuit [15, 16]. This conventional approach, along with specific risk factors for lung injury, such as lung ischemia–reperfusion [17], inflammation [18], and postoperative diaphragmatic dysfunction [19], could compound to worsen pulmonary atelectasis and the risk of postoperative pulmonary complications [20]. Notably, maintaining mechanical ventilation or a positive airway pressure during CPB improves gas exchange in the first postoperative hours [21] with beneficial effects on inflammatory response [22] and immune function [23]. Likewise, perioperative recruitment maneuvers and higher PEEP levels have been shown to attenuate atelectasis formation [24] and inflammation [25] in cardiac surgery patients. Consequently, maintaining ventilation during CPB in association with open-lung procedures before and after CPB, in order to maximize alveolar recruitment, could be an optimal strategy to prevent postoperative pulmonary complications.

However, such strategies remain highly controversial amongst perioperative physicians [26]. This is due to major surgical concerns related to limited visualization and access to the operative field produced by continuously expanded lungs, and the potential deleterious hemodynamic effects of higher ventilatory pressures in patients with severe cardiac disease [27]. As a result, the effect of an open-lung approach, including alveolar recruitment during the CPB period, on robust clinical outcomes is unknown in patients undergoing on-pump cardiac surgery.

We designed the open-lung Protective Ventilation in Cardiac Surgery (PROVECS) trial to assess whether an open-lung perioperative ventilation strategy, combining mechanical ventilation during CPB, perioperative recruitment maneuvers and higher PEEP levels, protects against postoperative pulmonary complications after elective on-pump cardiac surgery, as compared with a conventional ventilation strategy with no ventilation during CPB and lower PEEP levels.

Methods

Trial design

We conducted a pragmatic, multicenter, randomized, stratified, parallel-group clinical trial in five university hospitals in France. A detailed description of the study protocol has previously been published elsewhere and is available in Supplement 1 [28]. An ethical committee approved the study (CPP Sud Mediterranée I) on February 29, 2016 (ID-RCB 2016-A00352–49). An independent monitoring committee monitored patient data and safety issues. Written informed consent was obtained from all individual participants included in the study. The study was funded by the French Ministry of Health (PHRC-2015). There was no industry support or involvement in the trial.

Randomization and masking

Patients’ data were collected anonymously on an electronic platform, whereby each patient is assigned a unique identification number (CleanWEB^™_{, Tel}emedicine Technologies S.A.S., Boulogne-Billan-court, France). Randomization was performed with a computer-generated list, using permuted block of 4 design, which was drawn up by an independent operator before the beginning of the study. The allocation sequence was stratified by center. Local investigators performed the allocation before induction of general anesthesia using a web-based, secured system, centralized on the electronic platform. Participants and postoperative outcome assessors were blinded to the treatment arm. At the end of surgery, all the intraoperative data (including ventilator settings) were hidden on the electronic case report form by the intraoperative assessor.

Participants

We screened patients 18 years of age or older who were scheduled for elective cardiac surgery with general anesthesia, invasive mechanical ventilation, complete median sternotomy, conventional CPB, and aortic cross clamp. Patients were excluded in case of emergent or redo surgeries, preoperative hypoxemia, body mass index > 35 kg/m² or obstructive sleep apnea syndrome. Full list of exclusion criteria is available in the Supplement 2.

Interventions

Mechanical ventilation was performed using volume-controlled ventilation. All study patients were ventilated with low-tidal volumes before and after CPB (6 to 8 ml per kilogram of PBW, calculated using standard formula). Patients were assigned to one of the two strategies: in the open-lung ventilation strategy, ventilation was maintained during CPB (tidal volumes of 3 ml per kilogram of PBW, respiratory rate at 12 cycles per minute and fraction of inspired oxygen of 40%), PEEP level was set at 8 cm H ₂O from intubation in the operating room to extubation in the ICU, and recruitment maneuvers (continuous positive airway pressure maintained at 30 cm H₂O for 30 s) were systematically implemented at predefined stages in the surgical procedure; in the conventional ventilation strategy, mechanical ventilation was suspended during CPB, and PEEP level was set at 2 cm H₂O from intubation to extubation (Table 1).

Table 1.

Perioperative ventilatory protocol in each of the two strategies

	Conventional ventilation	Open-lung ventilation
Ventilation before CPB	Tidal volume 6–8 ml/kg PBW PEEP 2 cm of water RR for ETCO2 35–45 mmHg Lowest FiO2 to maintain SpO2 > 94% I:E ratio at 1:2	Tidal volume 6–8 ml/kg PBW PEEP 8 cm of water RR for E TCO2 35–45 mmHg Lowest FiO2 to maintain SpO2 > 94% I:E ratio at 1:2
Systematic recruitment maneuvers	No	Yesa
Ventilation during CPB	No	Yes
	CPAP 2 cm of water FiO2 40%	Tidal volume 3 mL/kg PBW PEEP 8 cm of water RR 12 cpm FiO2 40%
Ventilation after CPB (including in ICU)	Tidal volume 6–8 ml/kg PBW PEEP 2 cm of water RR for ETCO2 35–45 mmHg Lowest FiO2 to maintain SpO2 > 94% I:E ratio at 1:2	Tidal volume 6–8 ml/kg PBW PEEP 8 cm of water RR for E TCO2 35–45 mmHg Lowest FiO2 to maintain SpO2 > 94% I:E ratio at 1:2

cmH₂O centimeter of water, CPAP continuous positive airway pressure, ETCO₂ end-tidal CO₂, FiO₂ inspired oxygen fraction, I:E inspiratory time to expiratory time ratio, PEEP positive end-expiratory pressure, PBW predicted body weight, RR respiratory rate, SpO₂ oxygen saturation as detected by the pulse oximeter

^aIn the experimental open-lung group, recruitment maneuvers (continuous positive airway pressure maintained at 30 c mH₂O for 30 s) are systematically implemented at predefined stages in the surgical procedure: 1: After intubation and invasive arterial line placement. 2: After CPB initiation when targeted bloodflow is reached. 3: Before aortic de-clamping, after standard balloon de-airing maneuvers. 4: At ICU arrival with the ICU ventilator. 5: After each breathing circuit disconnection

Because surgeon’s discomfort and arterial hypotension were expected, we pragmatically standardized adjustments of intraoperative ventilatory settings in response to these. In case of surgical requirements, or because of a systolic arterial pressure lower than 80 mm Hg despite the adequate use of fluids and/or vasoactive drugs, interruption of a planned recruitment maneuver and transient lung deflation by lowering PEEP levels in stages of 1 cm H₂O were permitted in both ventilation strategies. The use of temporary apnea (continuous positive airway pressure set at the pre-apnea PEEP level) before, during or after CPB was also permitted on surgical demand. In both arms of the study, unplanned recruitment maneuvers and/or increased PEEP levels were permitted, as a rescue strategy, in case of critical intraoperative hypoxemia (peripheral capillary oxygen saturation < 92% with inspired oxygen fraction of 0.8).

During sternal sawing, PEEP was temporarily set to 0 cm H₂O to prevent pleural injury. Before aortic declamping, de-airing maneuvers by manual balloon ventilation were performed in both groups according to local protocols, with or without the use of transesophageal echocardiography, and under surgical guidance. During transport from the operating room to the ICU, ventilation was performed with a self-inflating balloon or transport ventilator with parameters set according to the treatment arm. All other ventilation procedures were identical in the two study groups (Table 1).

A fast-track extubation protocol, defined as extubation performed before the 6th postoperative hour, was followed. Perioperative care, including anesthesia and analgesia protocols, fluid management, transfusion strategy, or respiratory physiotherapy was performed at the discretion of the physician in charge. The use of noninvasive ventilation or nasal high-flow oxygen therapy was implemented according to local protocols. The prophylactic use (before any postoperative pulmonary complication) of these techniques was not permitted.

End points

The primary end point was a collapsed composite of postoperative pulmonary complications within the first 7 postoperative days. It included postextubation respiratory failure (graded as mild, moderate, or severe); bronchospasm, severe trachea–bronchial congestion, respiratory acidosis, suspected or confirmed pneumonia, pleural effusion, radiological atelectasis, acute respiratory distress syndrome, and fast-track extubation failure or the need for new invasive ventilation associated with hypoxemia (partial pressure of oxygen:fraction of inspired oxygen ratio of less than 300) (Supplement 2).

The secondary end points were each component of the primary end point analyzed individually; postoperative extrapulmonary complications, which included systemic inflammatory response syndrome, sepsis or septic shock, wound infection, pericardial tamponade, atrial fibrillation, cardiogenic pulmonary edema, acute kidney injury and delirium; and adverse events, defined as acute bleeding requiring reintervention, pneumothorax, and need for vasoactive drugs or high doses of inotropes (Supplement 2). Other secondary end points were use of high-flow nasal oxygen therapy, use of noninvasive or invasive ventilation, alive ICU-free days at day 7, and death at day 7. Alive ICU-free days at day 7 was defined as the difference, in days, of seven and ICU length of stay.

Statistical analysis

The sample size was determined to obtain 80% power to detect a 10-point difference in occurrence of postoperative pulmonary complications within 7 days after surgery between the two groups (25% in the control group vs 15% in the experimental group), based on previous reports [1]. With the threshold for statistical significance set at a p value of 0.05, 494 patients were needed (247 per group). The statistical analysis plan is available in Supplement 1. The primary analysis was performed on the modified intention-to-treat population (including all subjects who were randomized and were at least evaluated at baseline; patients who withdrew their consent were not included in the final analysis). No interim analysis was planned. The tests were two-tailed with a 5% significance level. The proportions of postoperative pulmonary complications within 7 days after surgery were compared between the two groups using the Chi square test (primary analysis), and the relative risk was presented with its 95% confidence interval (95% CI). Comparisons between the two groups were performed for the secondary end points: Chi square or Fisher’s exact test for proportions (multiple comparison corrections were performed using false discovery rate according to the number of comparisons), and Student t test for continuous variables (Alive ICU-free days). For the binary outcomes, relative risks and 95% CIs were calculated using the Wald likelihood ratio approximation test. The effect estimates were also presented as absolute difference (95% CI) or mean (standard deviation) difference (ICU-free days). Survival estimates were calculated according to the Kaplan–Meier method and compared using a log-rank test. Two post hoc analyses of the primary end point were performed: a potential center effect was assessed by mixed-effects modeling using the GLIMMIX procedure (SAS software, 9.4 version; center as a random effect, a logit-link function, and a binomial distribution function); heterogeneity of the strategy effect among pre-specified subgroups (sex, age, body mass index, type of surgery) using an interaction term between arm and subgroup in a generalized linear model considering a binomial distribution.

Results

Study population

From September 2016 through July 2018, a total of 1025 patients were assessed for eligibility. A total of 494 patients were randomly assigned to one of the two ventilation strategies (247 patients in each group). Three patients in the open-lung ventilation group and two patients in the conventional ventilation group did not receive the allocated intervention. One patient who was assigned to the open-lung ventilation strategy was secondarily excluded because of consent withdrawal for the use of data. Therefore, the primary analysis was performed on a modified intention-to-treat population: 246 patients in the open-lung ventilation group and 247 patients in the conventional ventilation group (Fig. 1). Baseline characteristics are reported in Table 2.

Fig. 1.

Patient randomization, follow-up, and analysis populations

Table 2.

Baseline characteristics of the trial population

Variables	Ventilation strategy, no. (%)
	Open-lung (n = 246)	Conventional (n = 247)
Age, mean (SD), years	66.1 ± 10.8	65.6 ± 11.8
Male sex	178/246 (72.4)	182/247 (73.7)
Height, mean (SD), cm	170.0 ± 9.0	170.3 ± 9.1
Body weight, mean (SD), kg	76.4 ± 12.7	76.6 ± 13.3
Body mass index, mean (SD)a	26.4 ± 3.5	26.4 ± 4.0
ASA score
≤ 2	28/244 (11.5)	30/245 (12.2)
3	214/244 (87.7)	207/245 (84.5)
4	2/244 (0.8)	8/245 (3.3)
Smoking status
Current smoker	28/244 (11.5)	28/245 (11.4)
Former smoker (weaning < 6 mo)	17/244 (7.0)	16/245 (6.5)
Alcohol intakeb	11/244 (4.5)	11/245 (4.5)
COPDc	7/245 (2.9)	8/245 (3.3)
Asthmac	10/244 (4.1)	9/245 (3.7)
Lower respiratory tract infection in the past 3 mo	2/244 (0.8)	3/245 (1.2)
Diabetes	50/244 (20.5)	47/245 (19.2)
Hypertension	142/244 (58.2)	135/245 (55.1)
Stroke	9/244 (3.7)	13/245 (5.3)
Loss of > 10% of body weight in previous 6 mo	2/244 (0.8)	0/245 (0)
Preoperative serum creatinine level > 2.26 mg/dl	1/244 (0.4)	0/245 (0)
Pathological chest X-ray	10 (4.1)	6 (3.7)
Preoperative LVEF, mean (SD), %	60.7 ± 8.7	61.4 ± 7.9
Preoperative right ventricle dilationd	4/244 (1.6)	2/245 (0.8)
Type of surgery
Isolated CABG	77/243 (31.7)	58/245 (23.7)
Isolated valve surgery	99/243 (40.7)	131/245 (53.5)
Other procedurese	67/243 (27.6)	56/245 (22.9)
Euroscore IIf, mean (SD), %	1.7 ± 1.2	1.8 ± 1.4

ASA American Society of Anesthesiology, CABG coronary artery bypass grafting, COPD chronic obstructive pulmonary disease, LVEF left ventricle ejection fraction

^aWeight in kilograms divided by the square of the height in meters

^bMore than two glasses of wine or equivalent per day

^cUnder chronic inhalation therapy

^d2D echocardiographic definition: right ventricle area/left ventricle area ratio > 1

^eThoracic aorta surgeries and combined procedures (valve + CABG, valve + aorta, aorta + CABG)

^fEuroscore II is a risk model that evaluate the risk of death after cardiac surgery

Intraoperative procedures

In the open-lung ventilation group, median (IQR) was 8 (8–8) cm H ₂O for highest and 8 (5–8) cm H ₂O for mode PEEP levels; and 5 (2–8) cm H₂O for lowest PEEP level. In patients assigned to the conventional ventilation strategy, analysis of applied intraoperative PEEP revealed a median (IQR) of 2 (2–2) cm H2O for lowest, highest and mode levels. In the open-lung ventilation group, 89.7% of the patients received at least three recruitment maneuvers and 76.5% of the patients received more than three recruitment maneuvers. Open-lung ventilation strategy significantly increases the use of adjustments because of arterial hypotension (difference, 17.7% [95% CI, 12.7% to 22.7%]; p < 0.001) or surgical requirements (difference, 58.9% [95% CI, 50.6% to 67.2%]; p < 0.001). CPB durations (p = 0.05) and incidence of platelets transfusion (difference, 5.0% [95% CI, 0.3% to 9.7%]; p = 0.04) were higher in the open-lung ventilation group. Use of rescue strategy for critical intraoperative hypoxemia was significantly lower in the open-lung ventilation group (difference, − 12.7% [95% CI, − 17.5% to − 7.9%]; p < 0.001). No significant differences were found with respect to the use of fluids, vasopressors or inotropes. At the end of surgery, dynamic and static respiratory compliance were greater in the open-lung ventilation than in the conventional ventilation group (Table 3).

Table 3.

Intraoperative procedures

Variable	Ventilation strategy, no. (%)
	Open-lung (n = 246)	Conventional (n = 247)	Absolute difference % (95%CI)	p value
Tidal volume, median (IQR), ml of PBW	6.9 (6.3–7.3)	7.0 (6.7–7.8)	–	0.005
PEEP, median (IQR), cm H2O
Lowest level	5 (2–8)	2 (2–2)	–	< 0.001
Highest level	8 (8–8)	2 (2–2)	–	< 0.001
Mode levela	8 (5–8)	2 (2–2)	–	< 0.001
Recruitment maneuverb				< 0.001
At least 1	236/243 (97.1)	19/245 (7.7)	89.4 [80.6 to 98.2]
At least 2	232/243 (95.4)	1/245 (0.4)	95.0 [86.2 to 100]
At least 3	218/243 (89.7)	1/245 (0.4)	89.3 [80.5 to 98.1]
At least 4	186/243 (76.5)	1/245 (0.4)	76.1 [67.5 to 84.7]
More than 4	166/243 (68.3)	1/245 (0.4)	67.9 [59.5 to 76.3]
Intervention adjustment for arterial hypotensionc	43/243 (17.7)	0/245 (0)	17.7 [12.7 to 22.7]	< 0.001
Intervention adjustment for surgical requirementsc	153/243 (63.0)	10/245 (4.1)	58.9 [50.6 to 67.2]	< 0.001
Rescue for hypoxemiad	4/243 (1.6)	35/245 (14.3)	− 12.7 [− 17.5 to − 7.9]	< 0.001
CPB duration, median (IQR), min	90 (74–119)	84 (67–108)	–	0.05
Aortic cross clamp duration, median (IQR), min	68 (52–91)	64 (48–83)	–	0.12
Mammary artery harvesting				0.15
None	144/243 (59.3)	166/245 (67.8)	− 8.5 [− 17.0 to 0]
Unilateral	40/243 (16.5)	33/245 (13.5)	3.0 [− 3.3 to 9.3]
Bilateral	59/243 (24.3)	46/245 (18.8)	5.5 [− 1.8 to 12.8]
Volume of fluids administered, median (IQR), ml
Crystalloid	2000 (1500–2500)	1900 (1500–2500)	–	0.19
Colloid	500 (0–900)	500 (0–750)	–	0.38
Blood products transfusion
Packed-red blood cells	21/243 (8.6)	17/245 (6.9)	1.7 [− 3.0 to 6.4]	0.48
Platelets	25/243 (10.3)	13/245 (5.3)	5.0 [0.3 to 9.7]	0.04
Fresh-frozen plasma	8/243 (3.3)	3/245 (1.2)	2.1 [− 0.5 to 4.7]	0.12
Cardioplegia, median (IQR), ml	81 (32–139)	92 (35–646)	–	0.15
Need for vasopressorse	99/243 (40.7)	89/245 (36.3)	4.4 [− 4.2 to 13.0]	0.31
Need for inotropese	27/243 (11.1)	29/245 (11.8)	− 0.7 [− 6.3 to 4.9]	0.80
Calculated respiratory compliance, median (IQR), ml per cm H2O
Dynamicf	36.0 (29.5 to 45.5)	31.0 (25.0 to 38.0)	–	< 0.001
Staticg	50.0 (41.5 to 62.5)	40.0 (33.0 to 50.0)	–	< 0.001

CPB cardiopulmonary bypass, ICU intensive care unit, IQR interquartile range, PBW predicted body weight, calculated as 50 + 0.91 × (height in cm – 152.4) for men and 45.5 + 0.91 × (height in cm − 152.4) for women, and PEEP positive end-expiratory pressure

^aMode PEEP level corresponds to intraoperative PEEP that was applied most of the time after reviewing ventilatory pressures in the 5-min trend table on the ventilator screen at the end of surgery

^bRecruitment maneuver effectively performed: continuous airway pressure at 30 cm H₂O for 30 s. In the open-lung ventilation group, recruitment maneuvers were planned after orotracheal intubation, at CPB initiation, at aortic declamping after de-airing maneuvers, at ICU arrival, and after every breathing circuit disconnection

^cAny type of adjustment; in case of systolic arterial pressure < 80 mm Hg despite the adequate use of fluids and/or vasoactive drugs or on surgical demand in case of intractable technical interferences: interruption of ongoing recruitment maneuver and/or reduction of PEEP level and/or temporary apnea (continuous positive airway pressure set at the pre-apnea PEEP level)

^dIn case of critical intraoperative hypoxemia (oxygen saturation < 92% despite inspired oxygen fraction of 0.8): implementation of unplanned recruitment maneuvers and/or increment of PEEP level and/or increment of inspired oxygen fraction (> 0.8)

^eOther than phenylephrine or ephedrine

^fCalculated at end of surgery as tidal volume (V_T)/(peak inspiratory pressure – PEEP)

^gCalculated at end of surgery as tidal volume (V_T)/(plateau pressure – PEEP)

Primary end point

Within the first 7 days, postoperative pulmonary complications occurred in 133 patients (54.7%) in the open-lung ventilation group and in 145 patients (59.2%) in the conventional ventilation group (difference, − 4.5% [95% CI, − 13.1% to 4.3%]; relative risk, 0.83 [95% CI, 0.58–1.19]; p = 0.32) (Table 4 and Fig. 2). The effect of ventilation strategy on the occurrence of the primary outcome was consistent across subgroups, including male vs female, age less than 65 vs 65 or greater, body mass index less than 30 vs 30 or greater, and isolated valve surgery or isolated CABG vs other types of surgery (See Table S1 in Supplement 2). No center effect was identified using mixed effects models (odd ratio, 0.83; 95% CI, 0.50–1.37; p = 0.36).

Table 4.

Primary and secondary end points

End point	Ventilation strategy, no. (% [95%CI])
	Open-lung (n = 246)	Conventional (n = 247)	Relative risk (95% CI)	Absolute difference (95%CI), %	p value
Primary end point
Collapsed composite of postoperative pulmonary complications at day 7	133/243 (54.7 [48.4–61.0])	145/245 (59.2 [53.0–65.4])	0.83 [0.58–1.19]	− 4.5 [− 13.1 to 4.3]	0.32
Secondary end points
Postoperative pulmonary complications at day 7a
Mild respiratory failureb	91/243 (37.4 [31.3–43.5])	97/245 (39.6, [33.5–45.7])	0.91 [0.63–1.32]	− 2.2 [− 10.7 to 6.4]	0.63 (0.99h)
Moderate respiratory failurec	18/243 (7.4 [4.1–10.7])	26/245 (10.6 [6.7–14.5])	0.67 [0.36–1.26]	− 3.2 [− 8.4 to 2.0]	0.22 (0.99h)
Severe respiratory failured	16/243 (6.6 [3.5–9.7])	13/245 (5.3 [2.5–8.1])	1.26 [0.59–2.67]	1.2 [− 3.2 to 5.6]	0.55 (0.99h)
Fast-track extubation failure with hypoxemiae	5/243 (2.1 [0–3.9])	7/245 (2.9 [0.8–5.0])	0.71 [0.22–2.27]	− 0.8 [− 4.0 to 2.2]	0.57 (0.99h)
New invasive ventilation with hypoxemiae	2/243 (0.8 [0–1.9])	6/245 (2.4 [0.5–4.3])	0.33 [0.07–1.65]	−1.6 [− 4.5 to 0.9]	0.28 (0.99h)
Bronchospasm	4/243 (1.6 [0–3.2])	5/245 (2.0 [0.0–3.8])	0.80 [0.21–3.03]	− 0.4 [− 3.2 to 2.4]	> 0.99 (0.99h)
Severe tracheo–bronchial congestion	17/243 (7.0 [3.8–10.2])	21/245 (8.6 [0.5–12.1])	0.80 [0.41–1.56]	− 1.6 [− 6.5 to 3.3]	0.52 (0.99h)
Respiratory acidosis	18/243 (7.4 [4.1–10.7])	20/245 (8.2 [0.5–11.6)	0.90 [0.46–1.74]	− 0.8 [− 5.7 to 4.1]	0.75 (0.99h)
Pneumonia
Suspected	15/243 (6.2 [3.2–9.2])	12/245 (4.9 [2.2–7.6])	1.27 [0.58–2.79]	1.3 [− 3.0 to 5.5]	0.54 (0.99h)
Confirmed	1/243 (0.4 [0–1.2])	2/245 (0.8 [0–1.9])	0.50 [0.04–5.57]	− 0.4 [− 2.5 to 1.6]	> 0.99 (0.99h)
Pleural effusion with need for further pleural drainage	1/243 (0.4 [0–1.2])	2/245 (0.8 [0–1.9])	0.50 [0.04–5.57]	− 0.4 [− 2.5 to 1.6]	> 0.99 (0.99h)
Radiological atelectasis	20/243 (8.2 [4.8–11.6])	30/245 (12.2 [8.1–16.3])	0.64 [0.35–1.17]	− 4.0 [− 9.5 to 1.4]	0.14 (0.99h)
ARDS	2/243 (0.8 [0–1.9])	2/245 (0.8 [0–1.9])	1.01 [0.14–7.22]	0	> 0.99 (0.99h)
Postoperative extra pulmonary complications at day 7a
SIRS	72/243 (29.6 [23.9–35.3])	76/245 (31.0 [25.2–36.8])	0.94 [0.64–1.38]	− 1.4 [− 9.5 to 6.7]	0.73 (0.83h)
Sepsis or septic shock	5/243 (2.1 [0–3.9])	3/245 (1.2 [0–2.6])	1.69 [0.40–7.19]	0.8 [− 1.8 to 3.6]	0.47 (0.83h)
Wound infection	1/243 (0.4 [0–1.2])	0/245 (0.0)	–	0.4 [− 1.2 to 2.3]	0.99 (0.99h)
Pericardial tamponade	2/243 (0.8 [0–1.9])	3/245 (1.2 2 [0–2.6])	0.67 [0.11–4.04]	− 0.4 [− 2.8 to 1.9]	0.66 (0.83h)
Postoperative atrial fibrillation	63/243 (25.9 [20.4–31.4])	71/245 (29.0 [23.3–34.7])	0.86 [0.58–1.28]	− 3.1 [− 10.9 to 4.9]	0.45 (0.83h)
Cardiogenic pulmonary edema	17/243 (7.0 [3.8–10.2])	22/245 (9.0 [5.4–12.6])	0.76 [0.39–1.47]	− 2.0 [− 7.0 to 2.9]	0.42 (0.83h)
Acute kidney injuryf	14/243 (5.8 [2.9–8.7])	10/245 (4.1 [1.6–6.6])	1.44 [0.62–3.30]	1.7 [− 2.3 to 5.8]	0.39 (0.83h)
Delirium	13/243 (5.3 [2.5–8.1])	16/245 (6.5 [3.4–9.6])	0.81 [0.38–1.72]	− 1.2 [− 5.6 to 3.2]	0.58 (0.83h)
Adverse events at day 7
Reintervention for acute bleeding
Before ICU arrival	8/243 (3.3 [1.1–5.5])	4/245 (1.6 [0–3.2])	2.05 [0.61–6.90]	1.7 [− 1.3 to 4.9]	0.24 (0.83h)
First 12 postoperative hours	8/243 (3.3 [1.1–5.5])	9/245 (3.7 [1.3–6.1])	0.89 [0.34–2.35]	− 0.4 [− 3.9 to 3.1]	0.82 (1.00h)
Pneumothorax	8/243 (3.3 [1.1–5.5])	6/245 (2.4 [0–4.3])	1.36 [0.46–3.97]	0.8 [− 2.4 to 4.2]	0.58 (1.00h)
Need for vasopressors	112/243 (46.1 [39.8–52.4])	99/245 (40.4 [34.3–46.5])	1.26 [0.88–1.80]	5.7 [− 3.1 to 14.3]	0.20 (0.83h)
LCOS with need for high dose of inotropesg	7/243 (2.9 [0–5.0])	7/245 (2.9 [0–5.0])	1.01 [0.35–2.92]	0	0.98 (1.00h)
Death	0/243 (0.0)	1/245 (0.4 [0–1.2])	–	− 0.4 [− 2.3 to 1.2]	1.00 (1.00h)
Health care utilization
Use of high-flow nasal oxygen therapy	21/243 (8.6 [5.1–12.1])	23/245 (9.4 [5.7–13.1])	0.91 [0.49–1.70]	− 0.8 [− 6.0 to 4.5]	0.77
Use of noninvasive ventilation	32/243 (13.2 [8.9–17.5])	38/245 (15.5 [11.0–20.0])	0.83 [0.50–1.37]	2.3 [− 8.6 to 3.9]	0.46
Use of new invasive mechanical ventilation	2/243 (0.8 [0–1.9])	6/245 (2.4 [0–4.3])	0.33 [0.07–1.65]	− 1.6 [− 4.5 to 0.8]	0.28
Alive ICU-free days at day 7, d
Median (IQR)	5 (3–5)	5 (3–5)	–	–
Mean (SD)	4.4 (1.3)	4.3 (1.3)	–	0.1 (0.1)i	0.51

ARDS acute respiratory distress syndrome, ICU intensive care unit, IQR interquartile range, LCOS low cardiac output syndrome, and SIRS systemic inflammatory response syndrome

^aFull definitions of postoperative pulmonary and extrapulmonary complications are available in the Supplement 2

^bPeripheral capillary oxygen saturation (SpO₂) < 90% or partial pressure of oxygen (PaO₂) < 60 mmHg after 10 min on ambient air: corrected by 1 to 3 L per minute of oxygen supply (nasal cannula)

^cSpO₂ < 90% or PaO₂ < 60 mmHg despite 3 L per minute of oxygen supply (nasal cannula): corrected by 4 to 10 L per minute of oxygen supply (face mask)

^dSpO₂ < 90% or PaO₂ < 60 mmHg despite 10 L per minute of oxygen supply (face mask): corrected by more than 10 L per minute of oxygen supply (high concentration mask or high-flow nasal oxygen therapy)

^ePartial pressure of arterial oxygen to fraction of inspired oxygen ratio ≤ 300 mmHg

^fKidney Disease Improving Global Outcomes stage 2 or 3

^gDobutamine > 8 μg kg⁻¹ min⁻¹ or milrinone > 0.8 μg kg⁻¹ min⁻¹

^hp value after multiple correction

ⁱEffect estimate is expressed as the mean difference (standard deviation)

Fig. 2.

Kaplan–Meier curve of the probability of the primary outcome by postoperative day 7. p = 0.29 (hazard ratio, 0.89; 95% confidence interval, 0.68 to 1.10) by the log-rank test for the between-group difference in the probability of the primary outcome

Secondary end points

At day 7, the proportion of patients who presented with an extrapulmonary complication, analyzed separately, did not differ between groups. There was no between-groups difference with regard to the occurrence of adverse events, the use of high-flow nasal oxygen therapy (difference,− 0.8% [95% CI, − 6.0% to 4.5%]; relative risk, 0.91 [95% CI, 0.49–1.70]; p = 0.77), noninvasive ventilation (difference, − 2.3% [95% CI, − 8.6% to 3.9%]; relative risk, 0.83 [95% CI, 0.50– 1.37]; p = 0.46) or new invasive mechanical ventilation (difference, − 1.6% [95% CI, − 4.5% to 0.8%]; relative risk, 0.33 [95% CI, 0.07–1.65]; p = 0.28). No significance between group difference was identified, with regard to secondary outcomes, after multiple comparison corrections. At day 7, the mean number of alive ICU-free days did not differ between groups (4.4 days in the open-lung group vs 4.3 days in the conventional group; mean ± SD difference, 0.1 ± 0.1 day; p = 0.51) (Table 4 and Fig. S2 in Supplement 2).

Discussion

Maintaining mechanical ventilation during CPB in association with perioperative recruitment maneuvers and higher PEEP levels did not reduce the incidence of postoperative pulmonary complications in patients undergoing on-pump cardiac surgery, as compared with a conventional strategy with no ventilation during CPB and lower PEEP levels.

Atelectasis has been associated with lung infection and could promote further mechanical lung injury from cyclic alveolar recruitment during ventilation [9]. Accordingly, an open-lung approach, by preventing atelectrauma, would be expected to result in a reduction in postoperative pulmonary complications in high-risk settings such as cardiac surgery. Indeed, previous studies indicated that such an approach improved functional residual capacity after extubation [29] and reduced inflammation after cardiac surgery with CPB [25].

As suggested by the improvement in pulmonary compliance and the reduced need to rescue critical intraoperative hypoxemia, open-lung ventilation, as applied in our trial, improved alveolar recruitment during general anesthesia. However, our results indicate that enhancing gas exchange and pulmonary mechanics during mechanical ventilation does not by itself improve postoperative clinical outcomes. Several factors could have contributed to this result. Apart from ventilation management, pain, fluid overload, prolonged bed rest, or diaphragmatic dysfunction may facilitate the development of pulmonary complications in the postextubation period [30]. Moreover, it has been suggested that the open-lung ventilation strategy may be harmful in terms of increased alveolar distension [31] and tidal strain [32]. This effect could mitigate the benefit of improved alveolar recruitment. Notably, anterior chest and pleural opening, intrinsic to open cardiac surgery, may amplify transpulmonary pressures [33, 34] in the non-dependent regions of the lung. Finally, besides the alveolar recruitment issue, the beneficial effect of maintaining mechanical ventilation during CPB, when lungs are no longer perfused, is controversial [35–37].

As expected, the open-lung ventilation strategy was associated with more frequent need for temporary adjustments due to iatrogenic arterial hypotension and surgical requirements. As a result, 23.5% of the patients assigned to the open-lung ventilation group did not receive more than three complete recruitment maneuvers. However, the number of recruitment maneuvers and the levels of PEEP have been empirically designed in the protocol and it is unclear if the recruiting efficacy of such maneuvers depends on a quantitative effect. In contrast, the conventional ventilation strategy minimizes interference with the surgical field and prevents hypotensive events. Importantly, the use of adjustments or rescue strategies did not compromise the reliability of our study, as between-groups differences on completed recruitment maneuvers and applied PEEP levels were both statistically and clinically (lower critical intraoperative hypoxemia in the open-lung group) significant.

Our findings are consistent with the previous results of two multicenter clinical trials [14, 38] in non-cardiac surgery that failed to demonstrate the superiority of systematic open-lung approaches in patients with normal lungs. Such previous studies and our results imply that use of intensive alveolar recruitment procedures should be reserved to selected patients presenting hypoxemia consistent with significant lung atelectasis, as a curative rather than a preventive approach. Moreover, timing of alveolar recruitment within the perioperative period is probably an underestimated factor. A delayed recruitment strategy, in patients presenting a highdegree of alveolar collapse, appears to be more relevant than starting alveolar recruitment procedures in the early stages of surgery, before any collapse occurs. This has been recently suggested by Costa Leme et al. [39] who reported a significant reduction in postoperative pulmonary complications when alveolar recruitment was applied postoperatively in cardiac surgery patients presenting hypoxemia at ICU arrival (partial pressure of oxygen:fraction of inspired oxygen ratio of less than 250 mmHg).

There are limitations to our trial. First, the observed rate of postoperative pulmonary complications, defined by a binary collapsed composite end point, was higher than previously advanced [1]. Nonetheless, this is the first prospective study to systematically assess lung function with daily, highly relevant to clinical practice, room air trials and to show the large proportion of patients presenting measurements consistent with respiratory failure after on-pump cardiac surgery. Such a difference between expected and observed incidence of pulmonary complications may have implications in the required sample size and the adequation of study power. Second, the use of composite outcomes offers the interest to reduce sample sizes; however, it may be responsible for difficulties in the interpretation of the results. Particularly, for each component included in our composite outcome, the differences in the degree of severity and the incidence represent a limitation. Nonetheless, postoperative pulmonary complications have been well described using composite outcomes in previous preeminent studies. Most importantly, our definitions of postoperative pulmonary complications are consistent with those previously used in such clinical trials [7, 14, 38]. Third, although present, the statistically significant difference in intraoperative tidal volume of 0.1 ml/kg of PBW between groups would be expected to be clinically and physiologically negligible. Fourth, we did not standardize perioperative fluid administration. However, no significant difference was found for administered intraoperative fluid volume and occurrence of cardiogenic pulmonary edema. Fifth, as use of noninvasive ventilation or high-flow nasal oxygen therapy might impact pulmonary complications [4, 40], the nonstandardization of their use is another limitation. However, preventive use of these techniques was excluded per protocol. Also, the proportion of patients that required these techniques was similar between groups, indicating minimal impact on the primary outcome. Finally, even if outcome assessors were blinded to the allocated treatment, the study was not strictly double-blind because intraoperative management was operated by unblinded investigators.

In conclusion, maintaining ventilation during CPB in association with perioperative recruitment maneuvers and higher PEEP levels to optimize perioperative lung recruitment does not reduce the incidence of postoperative pulmonary complications after on-pump cardiac surgery, as compared with use of no ventilation during CPB and lower perioperative PEEP levels.

Take-home message.

Maintaining ventilation during cardiopulmonary bypass along with perioperative recruitment maneuvers and higher levels of positive end-expiratory pressure was not effective in reducing postoperative pulmonary complications after on-pump cardiac surgery. This finding does not support the systematic use of such perioperative open-lung procedures in cardiac surgery patients.